Market research
PCK.AU PainChek Limited
AU AUD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 24M
- P/E ratio
- Not available
- Analyst target
- 0.08
- Dividend yield
- Not available
- Beta
- 0.47
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- AU000000PCK6
- Market cap
- 24M
- P/E ratio
- Not available
- Analyst target
- 0.08
- Dividend yield
- Not available
- Beta
- 0.47
About
About PainChek Limited
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PCK.AU discussion.
5 years, 5 months ago
PainChek Limited is currently in a long term downtrend where the price is trading 21.4% below its 200 day moving average.
From a valuation standpoint, the stock is 113.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 548.4.
PainChek Limited's total revenue sank by 30.9% to $127K since the same quarter in the previous year.
Its net income has increased by 86.3% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 45.0% to $-2M since the same quarter in the previous year.
Based on the above factors, PainChek Limited gets an overall score of 1/5.